Haisco Pharmaceutical Group Co., Ltd.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Haisco Pharmaceutical Group Co., Ltd.
RECRUITINGPhase 2NCT07363460
Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
A double-blind,placebo controlled,randomized Phase 2 study to evaluate the safety and tolerability of once-daily, oral administration of 200 or 300 mg HSK39297 tablets versus...
Sponsor: Haisco Pharmaceutical Group Co., Ltd.Enrolling: 1051 location
Lupus Nephritis (LN)
RECRUITINGPhase 2NCT07335055
A Study for HSK47388 in Participants With Ulcerative Colitis
The purpose of this protocol is to evaluate the efficacy and safety of HSK47388 as therapy in participants with moderately to severely active ulcerative colitis .
Sponsor: Haisco Pharmaceutical Group Co., Ltd.Enrolling: 1501 location
Ulcerative Colitis (UC)
RECRUITINGPhase 3NCT06660992
A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
This is a phase III, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of HSK31858 in non-cystic fibrosis bronchiectasis (NCFBE)...
Sponsor: Haisco Pharmaceutical Group Co., Ltd.Enrolling: 6692 locations
Non-cystic Fibrosis Bronchiectasis